Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use. Rosuvastatin may increase the risk of hematuria, proteinuria, and kidney failure, ...
Compared with atorvastatin, rosuvastatin was associated with an 8% higher risk of hematuria (blood in the urine), a 17% higher risk of proteinuria (protein in the urine), and a 15% higher risk of ...
Rosuvastatin given shortly before angiography can help prevent contrast-induced acute kidney injury (CI-AKI) in high-risk patients, whether they have diabetes and chronic kidney disease or present ...
Please provide your email address to receive an email when new articles are posted on . Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney ...
Use of OTC dietary supplements is increasingly common, sometimes replacing guideline-recommended therapies. Rosuvastatin was associated with larger reductions in LDL-C compared with placebo, fish oil, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results